Aqueous Two-Phase System for Dynamic Cytoskeletal Network Mimicry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current synthetic models fail to accurately replicate the dynamic assembly and dissociation of cytoskeletal networks and their interactions with biomolecular condensates, which are crucial for understanding cellular processes and diseases.

Innovation Solution

An aqueous two-phase system (ATPS) comprising two immiscible polymers, at least one of which is stimulus-responsive, such as poly(N-isopropylacrylamide) (PNIPAM) and dextran (DEX), that phase separates under external stimulation to form dynamic structures like solid spheres, porous networks, and core-shell spheres, mimicking cytoskeletal networks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If conventional synthetic models (oil-based emulsions, surfactant-stabilized droplets) are used to mimic subcellular structures, then the structural morphology can be controlled, but the biocompatibility deteriorates because oil phases inhibit biomolecule activities

Engineering Contradiction:
Improvestructural morphologyVSAvoidbiomolecule inhibition
Core Design Contradiction:
ShapeVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fundamental parameter of the continuous phase from oil-based to aqueous, transforming the system from non-biocompatible to biocompatible. This parameter change allows the system to maintain structural morphology control while eliminating the harmful inhibition of biomolecules by oil phases.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates an aqueous two-phase system that copies the essential functional features of conventional emulsion models (phase separation, droplet formation, interface dynamics) while using water instead of oil as the continuous phase, thereby achieving both structural fidelity and biocompatibility.

Inventive Principle:
Principle #26Copying

2Object-affected harmful factors

If aqueous two-phase systems are used to provide a biocompatible environment, then biomolecule activity is preserved, but the ability to form dynamic networks deteriorates because existing ATPS only form liquid-like organelles

Engineering Contradiction:
Improvebiomolecule compatibilityVSAvoidnetwork structure formation
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent employs a composite aqueous two-phase system combining two immiscible polymers (e.g., PNIPAM and dextran) with complementary properties: one forms the continuous phase while the other forms dispersed droplets. This composite structure enables simultaneous formation of liquid-like organelles and solid-like network structures, achieving both biomolecule compatibility and structural versatility.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent utilizes phase transition phenomena in the aqueous two-phase system, particularly the lower critical solution temperature (LCST) transition of PNIPAM, to dynamically control the formation and dissolution of network structures. This allows the system to transition between liquid and solid states, enabling dynamic network formation while maintaining biocompatibility.

Inventive Principle:
Principle #36Phase transitions

3Shape

If static network structures are generated using existing approaches (pore-forming agents, phase inversion), then the network morphology can be controlled, but the dynamic behavior deteriorates because cells require rapid assembly and dissociation

Engineering Contradiction:
Improvenetwork morphologyVSAvoidassembly dynamics
Core Design Contradiction:
ShapeVSDuration of action of moving object

Solution Approach 1:

The patent introduces dynamic control mechanisms into the aqueous two-phase system by incorporating stimuli-responsive polymers and controlling phase separation kinetics. This enables the network structures to dynamically assemble and dissociate in response to external stimuli, matching the dynamic behavior required for cellular functions while maintaining controllable morphology.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent utilizes parameter changes, particularly temperature changes via LCST transitions, to dynamically control network assembly and dissociation. By adjusting temperature or other parameters, the system can rapidly transition between network-formed and network-dissolved states, achieving the dynamic behavior necessary for cellular processes.

Inventive Principle:
Principle #35Parameter changes

4Adaptability or versatility

If the cytoskeleton is used to regulate intracellular transport and adjust organelle size, then essential cellular activities are controlled, but reproducing these dynamics in vitro remains challenging

Engineering Contradiction:
Improvecellular function regulationVSAvoidin vitro reproduction
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent creates an in vitro model that copies the essential dynamic behaviors of the cytoskeleton and biomolecular condensates using an aqueous two-phase system. By replicating phase separation dynamics and network formation/dissolution, the system enables study of cytoskeletal functions such as transport regulation and organelle size control without requiring complex cellular machinery.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent uses the aqueous two-phase system as an intermediary model that simplifies the complex in vivo cytoskeletal dynamics into controllable in vitro phenomena. The phase-separated polymers serve as mediators that replicate network behaviors while providing experimental accessibility and control for studying cellular regulation mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ATPS effectively mimics the dynamic assembly and dissociation of cytoskeletal networks, allowing for the investigation of their interactions with biomolecular condensates, and provides a biocompatible platform to study these interactions in vitro.

Implementation Method 1

aqueous liquid-liquid phase separation and liquid-solid phase separation (aqll-LS PS2)

Methodology Applied
Scientific EffectLiquid-liquid phase separation: Phase Change

Implementation Method 2

aqueous liquid-liquid phase separation and liquid-solid phase separation (aqll-LS PS2)

Methodology Applied
Scientific EffectLiquid-solid phase separation: Phase Change

Implementation Method 3

The biological network mimic can include a photothermal agent. The photothermal agent can be gold nanorods (GNRs), graphene, MXene, and/or carbon nanotubes.

Methodology Applied
Scientific EffectPhotothermal conversion:

Data Source

PatentUS20250199012A1Synergistic control and dynamic assembly of viscoelastic networks and biomolecular condensates by aqueous liquid-liquid phase separation and liquid-solid phase separation (aqll-LS PS2)
Publication Date: 2025.06.19 THE UNIVERSITY OF HONG KONG
  • US20250199012A1 patent drawing
  • US20250199012A1 patent drawing
  • US20250199012A1 patent drawing

AI summary

A biological network mimic for investigating subcellular structures and their interaction with biomolecular condensates is presented. The mimic is a stimulus-responsive polymer and a non-responsive polymer in an aqueous two-phase system (ATPS). One effective mimic is an aqueous two-phase system (ATPS) that combines poly (N-isopropylacrylamide) (PNIPAM) and dextran (DEX). The ATPS mimic, displays ultrasensitive thermo-induced aqueous liquid-liquid phase separation and liquid-solid phase separation (AqLL-LS PS2). Diverse structures, including networks, hollow spheres, and spinodal decomposition-like patterns, are generated by regulating component concentrations and temperatures. These structures are thermally reconfigurable. Networks can melt fused in sarcoma (FUS) condensates. The mimics provides methods to examine potential treatments of neurode-generative diseases by dissolving pathologically relevant biomolecular condensates.